Assured Consulting Solutions, LLC (ACS) is pleased to announce full registration of trademarks for DeepGovernance® and iTBMa® with the U.S. Patent and Trademark Office.
Registered trademarks for DeepGovernance and iTBMa represent the culmination of months of advanced technology service delivery for our Federal customers. By harnessing the power of data, ACS provides its customers advanced data-driven tools and technologies that operate as a force multiplier.
ACS Partner Ryan Feeney described what the trademarks mean for the company and its customers. “Through these trademarks, ACS is recognized as a thought leader that embraces data as the essential and enduring element of the future of computing. DeepGovernance represents the way and means that ACS uses to help our customers make the transformative leap into becoming a data-centric organization,” Feeney said. “As for iTBMa, ACS recognized the power and value that Technology Business Management brings to CIOs, but further enhances TBM by providing
Calviri, Inc., a biotech startup focused on ending deaths from cancer, announces that Skysong Innovations, the intellectual property management company for Arizona State University (“ASU”), granted Calviri an exclusive license to ASU’s Immunosignature patent portfolio. The portfolio consists of multiple granted and pending patents for the use and optimization of immunosignatures as an antibody-based diagnostic platform in the United States and the rest of the world.
The Immunosignature Technology was invented and originally developed by Stephen Albert Johnston, now CEO of Calviri, and his colleagues at ASU. The platform uses hundreds of thousands of chemically diverse peptides to provide an unbiased profile of an individual’s antibody repertoire. It has been applied to both infectious and chronic diseases in published reports. Initially intended as simply a diagnostic tool to detect disease onset, additional work has shown its potential for measuring disease severity and response to therapies.
Today Apple was granted a patent titled “Ultrasonic touch detection through display” Apple’s granted patent relates to system architectures, apparatus and methods for acoustic touch detection and exemplary applications of the system architectures, apparatus and methods. The technology will allow touch commands on an iDevice under water and more.
Apple notes in their patent filing that the position of an object touching a surface can be determined using time of flight (TOF) bounding box techniques, acoustic image reconstruction techniques, acoustic tomography techniques, attenuation of reflections from an array of barriers, or a two-dimensional piezoelectric receiving array, for example.
Acoustic touch sensing can utilize transducers, such as piezoelectric transducers, to transmit ultrasonic waves along a surface and/or through the thickness of an electronic device to the surface.
As the ultrasonic wave propagates, one or more objects (e.g., fingers, styli – Apple Pencil) in contact with the surface can interact with the
Technology giants such as Alibaba and IBM are eating startup innovators’ lunch. These behemoths are seeking to devour even more market share by publishing patents at unprecedented speed in emerging technologies such as blockchain.
As some of the richest companies on the planet, the corporations have the resources to manage the laborious search of existing patents and to overcome the outdated administrative hurdles so that they can file for intellectual property rights.
Patents are definitely old school. Patent laws started with the rise of the nation-state, so they began in the 18th century and were then fully developed in the 19th century. Some changes may have been made to reflect new technologies, but the basic patent laws haven’t evolved to meet the needs of the 21st century.
We’re patenting ideas based on today’s high-tech of artificial intelligence and blockchain with laws that were established centuries ago.
NEW YORK, Oct. 12, 2020 /PRNewswire/ — Bion Environmental Technologies, Inc. (OTC QB: BNET), a developer of comprehensive livestock waste treatment technology that generates multiple new revenue streams while largely mitigating the environmental impacts of large-scale livestock production, announced that it has received a new U.S. patent that strengthens the coverage of its third generation (3G) technology platform.
Patent No. 10,793,458 was issued by the U.S. Patent and Trademark Office on October 6, 2020. The patent describes the formation of ammonium bicarbonate in Bion’s 3G system from the ammonia, carbon dioxide and water vapor contained in the waste stream, and the further crystallization of that ammonium bicarbonate. Essentially, the patent covers the production of concentrated ammonia (nitrogen) fertilizer products in crystal (solid) form, from a livestock waste stream. The patent significantly strengthens Bion’s IP position, not only by covering current methods, but also by laying a foundation for future development.
Aspen Aerogels (ASPN) recently obtained a patent for the use of carbon aerogels in lithium-sulfur batteries. The patent has the potential to disrupt the electric vehicle and sustainable energy markets.
There is still a lot of research needed to understand how much this technology will improve lithium-sulfur batteries and if it will be enough to replace lithium-ion batteries. Even if it does, this change will happen gradually, but the change’s prospect is enough to be optimistic about the company in the long run.
Understanding the patent
To understand why lithium-sulfur batteries could replace lithium-ion batteries, we need to understand how these two technologies compare in the 3 key aspects of a battery for the industry: capacity, price, and the number of cycles of the battery.
Capacity is the amount of energy that a battery can accumulate. Current lithium-ion batteries can accumulate around 200 Wh/kg and have a theoretical maximum of
Hing Kai Chan, Professor of Operations Management at the University of Nottingham Ningbo China (UNNC), and his team recently gained authorisation from the National Intellectual Property Office for the patent “Digital watermarking method for 3D printing models”. The new patent tracks and protects intellectual property in 3D printing.
“The toughest problem in 3D printing is not technology, but the protection of intellectual property,” Professor Chan introduces. At present, the anti-counterfeiting of 3D printing model is mainly achieved by embedding digital watermark into triangular mesh data, but not all the model files are in triangular mesh format, and the embedded digital watermark may be lost in printing and manufacturing.
The model invented by Professor Chan’s team uses the algorithm to transform the 3D spatial matrix similarity problem into 2D image matching problem with high accuracy in the detection result. Moreover, the digital watermark is almost invisible to the naked eye, which
Folding phones seem to be the next thing in smartphone tech. With manufacturers like Samsung, Motorola, and Huawei already having folding smartphones in the market, it seems like Apple is also looking to get a piece of that pie. Now, since we’re talking Apple, the Cupertino-based giant is said to be looking at folding smartphones a little differently. An Apple patent published on the US Patent and Trademark Office reveals an idea of a ‘self-healing’ smartphone. The patent, filed by Apple in January this year, talks about “Electronic Devices With Flexible Display Cover Layers” with “self-healing” properties. The patent was filed on January 28. It named the inventors of the technology, along with the applicant name (Apple Inc), and the application number.
In the filing, Apple says that the self-healing material, which could be placed
Glaxo’s patent is for the use of the compound carvedilol to lessen the chance of death from congestive heart failure. The company claimed that Teva infringed the patent, even when it was selling its generic version of Coreg only for hypertension.
Teva began selling a generic version of the drug in 2007, when the main patent on it expired. Teva argued that it wasn’t responsible for the actions of doctors who prescribed the generic for congestive heart failure, because the doctors were acting based on knowledge of Coreg’s uses that they learned from Glaxo.
Glaxo argued that Teva marketed the generic version as being the same as Coreg, leading doctors to prescribe it for heart failure in violation of the patent. The patent expired in June 2015, but the June 2017 verdict was based on Teva’s sales of its generic before the patent expired.
Battles unfolding on several continents over who profits from connected cars, smarthomes, and robotic surgery may dwarf the size and scope of the tech industry’s first worldwide patent war — the one over smartphones.
Automakers are now in court fighting some of the same companies that phonemakers such as Apple Inc. had to pay billions of dollars for use of their wireless standards technology. Those companies — Qualcomm Inc., Nokia Oyj, and other telecommunications developers — may reap 5G royalties not only from “talking cars” but from products that will communicate wirelessly being planned in agriculture, medicine, appliances and other sectors.
“So many different types of companies have to find a way to get these deals done,” said Joe Siino, president of Dolby Laboratories Inc.’s patent licensing arm, which works with audio, wireless, broadcast and automotive industries. “It’s